|
|
 |
|
Viewing report
|
|
|
|
High-tech immunization
Datamonitor, Jan 2001
This brief analyzes three emerging technologies within the vaccine industry. Each of these technologies is assessed in terms of its function, current state of development, companies involved and the likely future effect its introduction will have on the vaccine market. The first technology, molecular evolution, offers great potential as a new drug discovery method and could help to reduce the costs of R&D. This brief attempts to elucidate how this technology will impact the vaccine market and how companies should react prior to and in response to its introduction. The second technology, nasal vaccine delivery, demonstrates one of several novel vaccine delivery mechanisms currently being developed. The brief discusses the medical and practical advantages of mucosal vaccines and the current state of development and company involvement in this field. Finally, the concept of personalized vaccine development as a result of gene chip technology is discussed in terms of its theoretical future application to vaccines. The brief analyzes the potential for gene chip technologies to affect vaccine development and market dynamics and provides recommendations for companies involved in this field to maintain or enhance their market share.
Customers who bought this item also bought
Human Vaccines - Global Strategic Business Report
Veterinary Vaccines - Global Strategic Business Report
HIV Vaccine Update: R&D Innovation Critical in the Wake of Recent Setbacks
Antiviral Therapeutics - Technologies, Markets and Companies
China Vaccine Market Report, 2007-2009
China Vaccine Market Report, 2007-2009
Gene Therapy - Technologies, Markets and Companies
Global Vaccine Market Forecast to 2012
Biopharmaceuticals in the US and European Markets
Global Vaccine Market Outlook (2007-2010)
Indian Vaccines Report
Pipeline And Commercial Insight: Influenza Vaccines - Pandemic Threat Revitalizes The Sector
|
|
|
|
